Sang Wan Gal

Title: Innovations of Sang Wan Gal in Chalcone Derivatives

Introduction

Sang Wan Gal is an accomplished inventor based in Jinju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chalcone derivatives. His research focuses on developing compounds that have potential therapeutic applications.

Latest Patents

Sang Wan Gal holds a patent for "Chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof." This patent discloses a novel chalcone derivative and its pharmaceutically acceptable salt. The method for preparing this compound involves reacting aminoacetophenone with sulfonyl chloride in the presence of an appropriate salt, followed by a reaction with hydroxybenzaldehyde using a suitable catalyst. The chalcone derivative exhibits strong enzyme inhibitory activities for glycosidase, making it effective in preventing and treating various diseases induced by glycosidase. Additionally, it has tyrosinase and melanin synthesis inhibitory activities, which can be utilized as a skin-whitening compound.

Career Highlights

Sang Wan Gal is affiliated with the Industry-Academic Cooperation Foundation at Gyeongsang National University. His work in this institution has allowed him to bridge the gap between academic research and practical applications in the pharmaceutical industry. His innovative approach has garnered attention in the scientific community.

Collaborations

Sang Wan Gal collaborates with notable colleagues, including Ki Hun Park and Jin Hyo Kim. Their combined expertise enhances the research and development of new pharmaceutical compounds.

Conclusion

Sang Wan Gal's contributions to the field of chalcone derivatives highlight his innovative spirit and dedication to advancing pharmaceutical science. His work not only addresses critical health issues but also opens new avenues for research and development in the industry.